NR4A1 limits CD8+ T Cell effector responses and protection in tuberculosis.

Saved in:
Bibliographic Details
Title: NR4A1 limits CD8+ T Cell effector responses and protection in tuberculosis.
Authors: Fatima S; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Chen Y; A*STAR Infectious Diseases Labs (ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, 138648, Singapore., Smulan L; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Satish B; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Jameson M; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Saini S; A*STAR Infectious Diseases Labs (ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, 138648, Singapore., Johnson C; Division of Hematology-Oncology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Tay A; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, 138684, Republic of Singapore., Foo S; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, 138684, Republic of Singapore., Rahmathulla H; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, 138684, Republic of Singapore., Balachander A; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, 138684, Republic of Singapore., Howland SW; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, 138684, Republic of Singapore., Kornfeld H; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.; These authors jointly supervised this work: Hardy Kornfeld and Amit Singhal., Singhal A; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.; A*STAR Infectious Diseases Labs (ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, 138648, Singapore.; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, 138684, Republic of Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore, 308232, Republic of Singapore.; These authors jointly supervised this work: Hardy Kornfeld and Amit Singhal.
Source: Research square [Res Sq] 2026 Jan 13. Date of Electronic Publication: 2026 Jan 13.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first